Nanobac Pharmaceuticals Inc. | Balance Sheet
Fiscal year is January-December. All values USD Thousands.
2003
2004
2005
2006
2007
Cash & Short Term Investments
49.80
17.90
9.00
39.50
3.90
Total Accounts Receivable
5.80
3.40
3.30
0.70
1.90
Inventories
16.20
70.60
117.30
66.40
10.30
Other Current Assets
14.90
23.60
43.70
19.90
14.70
Total Current Assets
86.60
115.50
173.30
126.50
30.80
Net Property, Plant & Equipment
135.30
125.00
107.00
60.30
37.50
Total Investments and Advances
-
-
20.70
-
-
Long-Term Note Receivable
70.10
68.10
-
-
-
Intangible Assets
7,952.10
9,375.70
8,668.80
7,579.40
7,142.50
Other Assets
-
-
-
58.50
9.00
Total Assets
8,244.10
9,684.30
8,969.70
7,824.70
7,219.80
ST Debt & Current Portion LT Debt
5,730.00
256.40
2,485.60
5,367.20
4,122.00
Accounts Payable
752.60
645.50
313.90
408.70
1,078.40
Other Current Liabilities
367.60
402.90
869.00
524.00
1,545.20
Total Current Liabilities
6,850.20
1,304.80
3,668.50
6,299.80
6,745.50
Long-Term Debt
-
-
-
961.50
961.50
Deferred Taxes
2,200.00
-
-
-
-
Other Liabilities
2,200.00
2,268.60
2,836.50
1,875.00
1,875.00
Total Liabilities
9,050.20
3,573.50
6,505.00
9,136.40
9,582.00
Common Equity (Total)
1,156.60
6,110.80
2,464.70
1,311.70
2,362.30
Total Shareholders' Equity
806.20
6,110.80
2,464.70
1,311.70
2,362.30
Total Equity
806.20
6,110.80
2,464.70
1,311.70
2,362.30
Liabilities & Shareholders' Equity
8,244.10
9,684.30
8,969.70
7,824.70
7,219.80
Preferred Stock (Carrying Value)
350.50
-
-
-
-
About Nanobac Pharmaceuticals
View Profile
